SAT0321 MKP-1 as a Protective Factor and Novel Drug Target in Scleroderma: MKP-1 Deficient Mice Develop More Severe Dermal Fibrosis in a Widely Used Experimental Model of Scleroderma

doi 10.1136/annrheumdis-2017-eular.4816
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism


Related search